Microbot Medical Inc. (MBOT)
USD 1.39
(-7.95%)
USD 1.39
(-7.95%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 8.32 Million USD | -12.69% |
| 2022 | 9.53 Million USD | -43.12% |
| 2021 | 16.76 Million USD | -36.2% |
| 2020 | 26.27 Million USD | -29.22% |
| 2019 | 37.12 Million USD | 509.62% |
| 2018 | 6.09 Million USD | -44.74% |
| 2017 | 11.02 Million USD | 227.2% |
| 2016 | 3.36 Million USD | -84.13% |
| 2015 | 21.21 Million USD | -34.56% |
| 2014 | 32.42 Million USD | -21.97% |
| 2013 | 41.55 Million USD | 37.74% |
| 2012 | 30.17 Million USD | 19.7% |
| 2011 | 25.2 Million USD | -17.63% |
| 2010 | 30.6 Million USD | -40.22% |
| 2009 | 51.19 Million USD | 24.16% |
| 2008 | 41.23 Million USD | -14.61% |
| 2007 | 48.28 Million USD | -27.78% |
| 2006 | 66.85 Million USD | 49.11% |
| 2005 | 44.83 Million USD | -5.86% |
| 2004 | 47.62 Million USD | 140.71% |
| 2003 | 19.78 Million USD | 74.66% |
| 2002 | 11.32 Million USD | -45.54% |
| 2001 | 20.8 Million USD | -30.18% |
| 2000 | 29.79 Million USD | 85.28% |
| 1999 | 16.08 Million USD | -51.12% |
| 1998 | 32.9 Million USD | -25.73% |
| 1997 | 44.3 Million USD | -24.14% |
| 1996 | 58.4 Million USD | 2.82% |
| 1995 | 56.8 Million USD | 76.4% |
| 1994 | 32.2 Million USD | -21.46% |
| 1993 | 41 Million USD | 16.48% |
| 1992 | 35.2 Million USD | 103.47% |
| 1991 | 17.3 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 7.36 Million USD | -11.53% |
| 2024 Q2 | 7.43 Million USD | 0.91% |
| 2023 Q4 | 8.32 Million USD | -6.31% |
| 2023 Q2 | 10.88 Million USD | 75.32% |
| 2023 Q1 | 6.2 Million USD | -34.91% |
| 2023 FY | 8.32 Million USD | -12.69% |
| 2023 Q3 | 8.88 Million USD | -18.34% |
| 2022 Q4 | 9.53 Million USD | 28.72% |
| 2022 Q1 | 13.68 Million USD | -18.4% |
| 2022 FY | 9.53 Million USD | -43.12% |
| 2022 Q3 | 7.4 Million USD | -29.72% |
| 2022 Q2 | 10.54 Million USD | -22.95% |
| 2021 Q2 | 21.86 Million USD | -9.54% |
| 2021 Q1 | 24.17 Million USD | -8.03% |
| 2021 FY | 16.76 Million USD | -36.2% |
| 2021 Q4 | 16.76 Million USD | -14.89% |
| 2021 Q3 | 19.7 Million USD | -9.9% |
| 2020 FY | 26.27 Million USD | -29.22% |
| 2020 Q2 | 29.9 Million USD | -4.44% |
| 2020 Q3 | 28.02 Million USD | -6.3% |
| 2020 Q1 | 31.29 Million USD | -15.7% |
| 2020 Q4 | 26.27 Million USD | -6.23% |
| 2019 Q2 | 12.57 Million USD | -9.58% |
| 2019 Q3 | 11.12 Million USD | -11.55% |
| 2019 Q1 | 13.9 Million USD | 128.36% |
| 2019 FY | 37.12 Million USD | 509.62% |
| 2019 Q4 | 37.12 Million USD | 233.78% |
| 2018 Q3 | 7.12 Million USD | -17.04% |
| 2018 FY | 6.09 Million USD | -44.74% |
| 2018 Q1 | 9.89 Million USD | -10.22% |
| 2018 Q2 | 8.59 Million USD | -13.16% |
| 2018 Q4 | 6.09 Million USD | -14.56% |
| 2017 Q4 | 11.02 Million USD | -10.36% |
| 2017 Q3 | 12.29 Million USD | -10.39% |
| 2017 Q2 | 13.71 Million USD | 141.66% |
| 2017 FY | 11.02 Million USD | 227.2% |
| 2017 Q1 | 5.67 Million USD | 68.56% |
| 2016 FY | 3.36 Million USD | -84.13% |
| 2016 Q1 | 17.41 Million USD | -17.91% |
| 2016 Q2 | 6.32 Million USD | -63.69% |
| 2016 Q4 | 3.36 Million USD | 57.06% |
| 2016 Q3 | 2.14 Million USD | -66.1% |
| 2015 FY | 21.21 Million USD | -34.56% |
| 2015 Q1 | 21.24 Million USD | -34.47% |
| 2015 Q2 | 36.98 Million USD | 74.04% |
| 2015 Q3 | 28.38 Million USD | -23.25% |
| 2015 Q4 | 21.21 Million USD | -25.24% |
| 2014 Q2 | 28.36 Million USD | -23.0% |
| 2014 Q4 | 32.42 Million USD | -24.18% |
| 2014 Q1 | 36.83 Million USD | -11.37% |
| 2014 FY | 32.42 Million USD | -21.97% |
| 2014 Q3 | 42.77 Million USD | 50.81% |
| 2013 Q3 | 32.31 Million USD | -5.1% |
| 2013 Q4 | 41.55 Million USD | 28.59% |
| 2013 FY | 41.55 Million USD | 37.74% |
| 2013 Q1 | 24.76 Million USD | -17.92% |
| 2013 Q2 | 34.05 Million USD | 37.51% |
| 2012 Q2 | 16.95 Million USD | -14.99% |
| 2012 Q3 | 29.65 Million USD | 74.93% |
| 2012 Q4 | 30.17 Million USD | 1.73% |
| 2012 FY | 30.17 Million USD | 19.7% |
| 2012 Q1 | 19.94 Million USD | -20.87% |
| 2011 Q3 | 22.46 Million USD | -14.67% |
| 2011 Q1 | 32.24 Million USD | 5.38% |
| 2011 Q4 | 25.2 Million USD | 12.22% |
| 2011 FY | 25.2 Million USD | -17.63% |
| 2011 Q2 | 26.32 Million USD | -18.38% |
| 2010 Q1 | 42.99 Million USD | -16.0% |
| 2010 FY | 30.6 Million USD | -40.22% |
| 2010 Q4 | 30.6 Million USD | -14.9% |
| 2010 Q3 | 35.95 Million USD | -15.18% |
| 2010 Q2 | 42.39 Million USD | -1.41% |
| 2009 Q1 | 42.16 Million USD | 2.26% |
| 2009 FY | 51.19 Million USD | 24.16% |
| 2009 Q4 | 51.19 Million USD | 13.95% |
| 2009 Q3 | 44.92 Million USD | -8.45% |
| 2009 Q2 | 49.07 Million USD | 16.39% |
| 2008 Q1 | 39.58 Million USD | -18.0% |
| 2008 FY | 41.23 Million USD | -14.61% |
| 2008 Q4 | 41.23 Million USD | 44.75% |
| 2008 Q3 | 28.48 Million USD | -15.69% |
| 2008 Q2 | 33.78 Million USD | -14.66% |
| 2007 Q1 | 60.99 Million USD | -8.77% |
| 2007 Q2 | 59.01 Million USD | -3.25% |
| 2007 FY | 48.28 Million USD | -27.78% |
| 2007 Q4 | 48.28 Million USD | -9.12% |
| 2007 Q3 | 53.12 Million USD | -9.97% |
| 2006 Q1 | 40.14 Million USD | -10.47% |
| 2006 Q3 | 64.45 Million USD | -8.31% |
| 2006 FY | 66.85 Million USD | 49.11% |
| 2006 Q2 | 70.29 Million USD | 75.1% |
| 2006 Q4 | 66.85 Million USD | 3.73% |
| 2005 Q1 | 44.16 Million USD | -7.26% |
| 2005 FY | 44.83 Million USD | -5.86% |
| 2005 Q2 | 42.94 Million USD | -2.77% |
| 2005 Q4 | 44.83 Million USD | -1.36% |
| 2005 Q3 | 45.45 Million USD | 5.84% |
| 2004 Q1 | 16.76 Million USD | -15.28% |
| 2004 FY | 47.62 Million USD | 140.71% |
| 2004 Q2 | 32.17 Million USD | 91.93% |
| 2004 Q3 | 29.6 Million USD | -7.98% |
| 2004 Q4 | 47.62 Million USD | 60.88% |
| 2003 Q4 | 19.78 Million USD | 77.92% |
| 2003 Q1 | 9.09 Million USD | -19.74% |
| 2003 Q3 | 11.12 Million USD | -18.45% |
| 2003 Q2 | 13.63 Million USD | 49.97% |
| 2003 FY | 19.78 Million USD | 74.66% |
| 2002 Q1 | 17.9 Million USD | -13.91% |
| 2002 FY | 11.32 Million USD | -45.54% |
| 2002 Q4 | 11.32 Million USD | -18.64% |
| 2002 Q3 | 13.92 Million USD | -8.73% |
| 2002 Q2 | 15.25 Million USD | -14.81% |
| 2001 Q3 | 19.15 Million USD | 9.85% |
| 2001 Q4 | 20.8 Million USD | 8.63% |
| 2001 FY | 20.8 Million USD | -30.18% |
| 2001 Q1 | 21.5 Million USD | -27.82% |
| 2001 Q2 | 17.43 Million USD | -18.94% |
| 2000 Q1 | 12.33 Million USD | -23.29% |
| 2000 FY | 29.79 Million USD | 85.28% |
| 2000 Q2 | 32.38 Million USD | 162.56% |
| 2000 Q3 | 41.63 Million USD | 28.54% |
| 2000 Q4 | 29.79 Million USD | -28.43% |
| 1999 Q4 | 16.08 Million USD | -16.24% |
| 1999 Q1 | 28.6 Million USD | -13.07% |
| 1999 FY | 16.08 Million USD | -51.12% |
| 1999 Q2 | 26.2 Million USD | -8.39% |
| 1999 Q3 | 19.2 Million USD | -26.72% |
| 1998 Q4 | 32.9 Million USD | -1.79% |
| 1998 Q2 | 39.6 Million USD | -0.25% |
| 1998 Q1 | 39.7 Million USD | -10.38% |
| 1998 FY | 32.9 Million USD | -25.73% |
| 1998 Q3 | 33.5 Million USD | -15.4% |
| 1997 FY | 44.3 Million USD | -24.14% |
| 1997 Q2 | 51.3 Million USD | -6.39% |
| 1997 Q3 | 50 Million USD | -2.53% |
| 1997 Q4 | 44.3 Million USD | -11.4% |
| 1997 Q1 | 54.8 Million USD | -6.16% |
| 1996 FY | 58.4 Million USD | 2.82% |
| 1996 Q4 | 58.4 Million USD | 15.19% |
| 1996 Q3 | 50.7 Million USD | -2.31% |
| 1996 Q1 | 52.6 Million USD | -7.39% |
| 1996 Q2 | 51.9 Million USD | -1.33% |
| 1995 Q2 | 43.3 Million USD | 21.29% |
| 1995 FY | 56.8 Million USD | 76.4% |
| 1995 Q4 | 56.8 Million USD | -7.64% |
| 1995 Q3 | 61.5 Million USD | 42.03% |
| 1995 Q1 | 35.7 Million USD | 10.87% |
| 1994 Q1 | 38.1 Million USD | -7.07% |
| 1994 Q4 | 32.2 Million USD | -4.17% |
| 1994 Q3 | 33.6 Million USD | -10.88% |
| 1994 Q2 | 37.7 Million USD | -1.05% |
| 1994 FY | 32.2 Million USD | -21.46% |
| 1993 Q2 | 27.9 Million USD | -12.81% |
| 1993 Q4 | 41 Million USD | 0.0% |
| 1993 FY | 41 Million USD | 16.48% |
| 1993 Q1 | 32 Million USD | -9.09% |
| 1992 Q4 | 35.2 Million USD | 0.0% |
| 1992 FY | 35.2 Million USD | 103.47% |
| 1991 Q4 | 17.3 Million USD | 0.0% |
| 1991 FY | 17.3 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 180.36 Million USD | 95.383% |
| AngioDynamics, Inc. | 317.67 Million USD | 97.379% |
| AtriCure, Inc. | 613.93 Million USD | 98.644% |
| Avinger, Inc. | 13.77 Million USD | 39.528% |
| Azenta, Inc. | 2.88 Billion USD | 99.711% |
| BioLife Solutions, Inc. | 412.71 Million USD | 97.982% |
| The Cooper Companies, Inc. | 11.65 Billion USD | 99.929% |
| Daxor Corporation | 34.86 Million USD | 76.119% |
| Ekso Bionics Holdings, Inc. | 28.91 Million USD | 71.205% |
| Femasys Inc. | 27.75 Million USD | 69.999% |
| GlucoTrack, Inc. | 4.9 Million USD | -69.766% |
| Harvard Bioscience, Inc. | 137.36 Million USD | 93.938% |
| Hologic, Inc. | 9.15 Billion USD | 99.909% |
| ICU Medical, Inc. | 4.37 Billion USD | 99.81% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 99.946% |
| KORU Medical Systems, Inc. | 28.46 Million USD | 70.742% |
| LeMaitre Vascular, Inc. | 346.77 Million USD | 97.599% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -33.901% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -33.901% |
| Masimo Corporation | 3.04 Billion USD | 99.726% |
| Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | 95.156% |
| Merit Medical Systems, Inc. | 2.32 Billion USD | 99.642% |
| Nephros, Inc. | 11.86 Million USD | 29.795% |
| NovoCure Limited | 1.14 Billion USD | 99.273% |
| NEXGEL, Inc. | 9.95 Million USD | 16.354% |
| NEXGEL, Inc. | 9.95 Million USD | 16.354% |
| Singular Genomics Systems, Inc. | 265.46 Million USD | 96.863% |
| OraSure Technologies, Inc. | 482.84 Million USD | 98.275% |
| Pro-Dex, Inc. | 54.21 Million USD | 84.639% |
| Pulse Biosciences, Inc. | 60.8 Million USD | 86.305% |
| Predictive Oncology Inc. | 14.41 Million USD | 42.243% |
| Precision Optics Corporation, Inc. | 16.91 Million USD | 50.764% |
| QuidelOrtho Corporation | 8.56 Billion USD | 99.903% |
| Repligen Corporation | 2.82 Billion USD | 99.705% |
| Sanara MedTech Inc. | 73.87 Million USD | 88.728% |
| STAAR Surgical Company | 488.69 Million USD | 98.296% |
| Sharps Technology, Inc. | 11.78 Million USD | 29.368% |
| Utah Medical Products, Inc. | 135.45 Million USD | 93.853% |
| DENTSPLY SIRONA Inc. | 7.37 Billion USD | 99.887% |
| Jin Medical International Ltd. | 32.9 Million USD | 74.693% |